Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation
Clinical trial NCT06050980 · RECRUITING
Trial details
- NCT number
- NCT06050980
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-27
- Primary completion
- 2025-08-30
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.